# Correction of Metabolic Acidosis in End Stage Renal Disease (ESRD)

> **NCT01640119** · PHASE3 · UNKNOWN · sponsor: **Azienda Sanitaria ASL Avellino 2** · enrollment: 728 (estimated)

## Conditions studied

- Metabolic Acidosis

## Interventions

- **DIETARY_SUPPLEMENT:** Bicarbonate

## Key facts

- **NCT ID:** NCT01640119
- **Lead sponsor:** Azienda Sanitaria ASL Avellino 2
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-07
- **Primary completion:** 2014-12
- **Final completion:** 2017-12
- **Target enrollment:** 728 (ESTIMATED)
- **Last updated:** 2014-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01640119

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01640119, "Correction of Metabolic Acidosis in End Stage Renal Disease (ESRD)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01640119. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*